Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * | KEGG DRUG * | DrugBank | 指定難病告示番号 * |
1 | Alanine, aspartate and glutamate metabolism |
4件: ABAT, ALDH5A1, GAD1, GAD2 | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
2 | Aldosterone synthesis and secretion |
3件: CACNA1G, CACNA1H, CACNA1I | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
3 | beta-Alanine metabolism |
3件: ABAT, GAD1, GAD2 | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
4 | Butanoate metabolism |
4件: ABAT, ALDH5A1, GAD1, GAD2 | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
5 | Calcium signaling pathway |
3件: CACNA1G, CACNA1H, CACNA1I | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
6 | Circadian entrainment |
3件: CACNA1G, CACNA1H, CACNA1I | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
7 | Cortisol synthesis and secretion |
3件: CACNA1G, CACNA1H, CACNA1I | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
8 | Cushing syndrome |
3件: CACNA1G, CACNA1H, CACNA1I | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
9 | GABAergic synapse |
3件: ABAT, GAD1, GAD2 | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
10 | GnRH secretion |
3件: CACNA1G, CACNA1H, CACNA1I | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
11 | MAPK signaling pathway |
3件: CACNA1G, CACNA1H, CACNA1I | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
12 | Metabolic pathways |
4件: ABAT, ALDH5A1, GAD1, GAD2 | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
13 | Propanoate metabolism |
1件: ABAT | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
14 | Taurine and hypotaurine metabolism |
2件: GAD1, GAD2 | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
15 | Type I diabetes mellitus |
2件: GAD1, GAD2 | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
16 | Type II diabetes mellitus |
1件: CACNA1G | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |
17 | Valine, leucine and isoleucine degradation |
1件: ABAT | D00399 | Valproic Acid | 14件: 2, 3, 5, 8, 26, 34, 65, 89, 90, 102, 222, 233, 256, 331 |